ArticleAntimicrobial agents and chemotherapy2019

Pharmacokinetics, Safety, and Tolerability of Intravenous Durlobactam and Sulbactam in Subjects with Renal Impairment and Healthy Matched Control Subjects.

John O'Donnell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.